Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4203144 | 1.00 | KDM4E (0.34) | KDM4ECYP2D6CYP1A2CYP2C19POLB | |
| SCHEMBL4202290 | 0.92 | MEN1 (0.32) | KDM4ETSHRALDH1A1 | |
| SCHEMBL3411672 | 0.84 | HTR7 (0.32) | — | |
| SCHEMBL3413738 | 0.83 | KDM1A (0.35) | KDM4ETSHRALDH1A1 | |
| SCHEMBL4206766 | 0.83 | IKBKB (0.31) | KDM4ECYP2D6CYP1A2CYP2C19 | |
| SCHEMBL4206306 | 0.81 | HTR4 (0.33) | KDM4EALDH1A1NPSR1 | |
| SCHEMBL4210058 | 0.80 | HTR4 (0.34) | KDM4EALDH1A1 | |
| SCHEMBL3414051 | 0.80 | HTR1A (0.33) | — | |
| SCHEMBL4207946 | 0.80 | PKM (0.39) | KDM4EPOLBTSHRALDH1A1NPSR1 | |
| SCHEMBL4958781 | 0.80 | PKM (0.39) | KDM4EPOLBTSHRALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1871772-A1 | QUINOLINONE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS | Theravance, Inc. (US) | 2008-01-02 | — | — | EP | claimed |
| WO-2006094063-A1 | QUINOLINONE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS | THERAVANCE, INC. (US) | 2006-09-08 | — | — | WO | claimed |